Pages that link to "Q36603837"
Jump to navigation
Jump to search
The following pages link to Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature (Q36603837):
Displaying 50 items.
- Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention (Q26747279) (← links)
- Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. (Q30370475) (← links)
- The preclinical natural history of serous ovarian cancer: defining the target for early detection (Q33487678) (← links)
- Early detection of ovarian cancer (Q34094731) (← links)
- Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? (Q34125241) (← links)
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (Q34172655) (← links)
- The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. (Q34288214) (← links)
- Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis (Q34625221) (← links)
- Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer (Q35219159) (← links)
- Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteome (Q35308231) (← links)
- Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review (Q35788778) (← links)
- Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection (Q36039369) (← links)
- Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act. (Q36313479) (← links)
- Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study (Q36369334) (← links)
- The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids (Q36791100) (← links)
- Mathematical models of breast and ovarian cancers. (Q37014152) (← links)
- Ovarian cancer stroma: pathophysiology and the roles in cancer development (Q37017056) (← links)
- Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention (Q37125079) (← links)
- Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) (Q37163464) (← links)
- Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125. (Q37406838) (← links)
- BRCA and Early Events in the Development of Serous Ovarian Cancer. (Q37513137) (← links)
- Pathogenesis and heterogeneity of ovarian cancer. (Q37546692) (← links)
- HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases (Q37611329) (← links)
- BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations (Q38039167) (← links)
- Hereditary gynaecological malignancies: advances in screening and treatment (Q38067433) (← links)
- Fallopian tube precursors of ovarian low- and high-grade serous neoplasms (Q38067435) (← links)
- Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management (Q38978839) (← links)
- Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. (Q40028239) (← links)
- Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (Q43625600) (← links)
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. (Q45507609) (← links)
- Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation (Q46109381) (← links)
- Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube (Q46366935) (← links)
- Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary (Q46904235) (← links)
- "Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty". (Q47162185) (← links)
- Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions (Q49184692) (← links)
- Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers (Q51755477) (← links)
- The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer. (Q53234024) (← links)
- [Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria]. (Q53305324) (← links)
- [Hereditary breast and ovarian cancer]. (Q53738265) (← links)
- Cell Origins of High-Grade Serous Ovarian Cancer (Q59809876) (← links)
- The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer (Q61925515) (← links)
- infection in primary fallopian tube and high-grade serous ovarian cancers: a pilot study (Q64062380) (← links)
- Fallopian tube cancer: stepchild or mother? (Q80134053) (← links)
- Hereditary cancer seen by the pathologist (Q82339490) (← links)
- Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube? (Q82682167) (← links)
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin? (Q85068531) (← links)
- Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later (Q87293688) (← links)
- Of mice and women - Non-ovarian origins of "ovarian" cancer (Q88847543) (← links)
- Serous tubal intraepithelial neoplasia: the concept and its application (Q89923260) (← links)
- Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids (Q95933360) (← links)